Literature DB >> 20031121

A unique unresponsive CD4+ T cell phenotype post TCR antagonism.

Lindsay J Edwards1, Brian D Evavold.   

Abstract

The functional outcomes of the T cell's interaction with the peptide:MHC complex can be dramatically altered by the introduction of a single amino acid substitution. Previous studies have described the varied effects of these altered peptide ligands (APL) on T cell responses. These outcomes of T cell interaction with an APL include the induction of clonal unresponsiveness (anergy) and inhibition of T cell responses (antagonism). The phenotype of peptide-induced anergy, i.e. low proliferation and low IL-2 production, has been extensively described, and a number of groups have demonstrated antagonism. However, the response of T cells to an agonist ligand after encountering an antagonistic stimulus has not been previously characterized. Here, we show that T cells post-antagonism fail to proliferate but produce large quantities of IL-2 upon stimulation with their wild type ligand. This unique phenotype is not due to differences in IL-2 receptor expression or rates of apoptosis, and cannot be overcome by the addition of recombinant IL-2. The response of CD4 T cells to agonist stimulation after encountering an antagonist is a novel phenotype, and is distinct from previously described forms of anergy. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031121      PMCID: PMC2838172          DOI: 10.1016/j.cellimm.2009.11.002

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  34 in total

1.  Cross-antagonism of a T cell clone expressing two distinct T cell receptors.

Authors:  B N Dittel; I Stefanova; R N Germain; C A Janeway
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

2.  Induction of T cell anergy by low numbers of agonist ligands.

Authors:  L C Korb; S Mirshahidi; K Ramyar; A A Sadighi Akha; S Sadegh-Nasseri
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

3.  Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism.

Authors:  M F Bachmann; D E Speiser; A Zakarian; P S Ohashi
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

4.  Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction.

Authors:  S J Haque; P Harbor; M Tabrizi; T Yi; B R Williams
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

5.  Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.

Authors:  L Frasca; P Del Porto; L Tuosto; B Marinari; C Scottà; M Carbonari; A Nicosia; E Piccolella
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

6.  Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities.

Authors:  J M Robertson; B D Evavold
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

7.  Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade.

Authors:  M A Purbhoo; A K Sewell; P Klenerman; P J Goulder; K L Hilyard; J I Bell; B K Jakobsen; R E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

8.  Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells.

Authors:  T S Migone; N A Cacalano; N Taylor; T Yi; T A Waldmann; J A Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  TCR transgenic mice in which usage of transgenic alpha- and beta-chains is highly dependent on the level of selecting ligand.

Authors:  G J Kersh; D L Donermeyer; K E Frederick; J M White; B L Hsu; P M Allen
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

10.  Inhibition of altered peptide ligand-mediated antagonism of human GAD65-responsive CD4+ T cells by non-antagonizable T cells.

Authors:  John A Gebe; Susan A Masewicz; Sharon A Kochik; Helena Reijonen; Gerald T Nepom
Journal:  Eur J Immunol       Date:  2004-12       Impact factor: 5.532

View more
  3 in total

Review 1.  T cell recognition of weak ligands: roles of signaling, receptor number, and affinity.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

2.  Subtle changes in TCRα CDR1 profoundly increase the sensitivity of CD4 T cells.

Authors:  Jennifer N Lynch; David L Donermeyer; K Scott Weber; David M Kranz; Paul M Allen
Journal:  Mol Immunol       Date:  2012-09-14       Impact factor: 4.407

3.  Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus.

Authors:  Sean A Nelson; Andrea J Sant
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.